Ms contin and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ms contin (morphine sulfate) and Pataday (olopatadine hydrochloride). Common drug interactions include fall among females.

The phase IV clinical study analyzes what interactions people have when they take Ms contin and Pataday. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.



On Jul, 11, 2026

11 people who take Ms contin and Pataday together, and have interactions are studied.

Ms contin and Pataday drug interactions.

What are the common drug interactions of Ms Contin and Pataday, by gender? *:

female:

  1. Fall
  2. Weight increased
  3. Pneumonia
  4. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  5. Productive cough
  6. Rash pruritic (redness with itching)
  7. Respiratory tract congestion (blockage on respiratory system)
  8. Rhinorrhoea (watery mucus discharge from the nose)
  9. Sinusitis (inflammation of sinus)
  10. Rash

male:

n/a

What are the common drug interactions of Ms Contin and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Depressed mood
  2. Irritability
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Weight increased
  5. Weight loss poor

40-49:

n/a

50-59:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Abdominal pain upper
  3. Death
  4. Diarrhoea
  5. Nausea (feeling of having an urge to vomit)
  6. Oropharyngeal pain
  7. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

60+:

  1. Fall
  2. Dry eye (lack of adequate tears)
  3. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  4. Productive cough
  5. Rash pruritic (redness with itching)
  6. Respiratory tract congestion (blockage on respiratory system)
  7. Rhinorrhoea (watery mucus discharge from the nose)
  8. Sinusitis (inflammation of sinus)
  9. Weight increased
  10. Rash

What are the existing conditions these people have? *

  1. Migraine (headache): 4 people, 36.36%
  2. Immune System Disorder: 3 people, 27.27%
  3. Multiple Myeloma (cancer of the plasma cells): 3 people, 27.27%
  4. Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 18.18%
  5. Vulvovaginal Dryness: 1 person, 9.09%
  6. Depression: 1 person, 9.09%
  7. Eye Allergy: 1 person, 9.09%
  8. Fever: 1 person, 9.09%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 9.09%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ms contin and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ms contin and Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and olopatadine hydrochloride (the active ingredients of Ms contin and Pataday, respectively), and Ms contin and Pataday (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: